Omid (OMID, $0.03) was one of the top gainers for the month, rising +2 to $0.03 per share. A.I.dvisor analyzed 217 stocks in the Pharmaceuticals: Other Industry for the month ending February 19, 2025 and discovered that of them (5) exhibited an Uptrend while of them (4) exhibited a Downtrend.